Literature DB >> 21316344

Acute suppression of apo B secretion by insulin occurs independently of MTP.

Janet D Sparks1, Jeffrey M Chamberlain, Colleen O'Dell, Irani Khatun, M Mahmood Hussain, Charles E Sparks.   

Abstract

Secretion of apolipoprotein (apo) B-containing lipoproteins by the liver depends mainly upon apo B availability and microsomal triglyceride transfer protein (MTP) activity and is subject to insulin regulation. Hepatic MTP mRNA expression is negatively regulated by insulin which correlates with inhibition of apo B secretion suggesting that insulin might suppress apo B secretion through an MTP-dependent mechanism. To investigate this possibility, we examined the acute effect of insulin on hepatic MTP expression and activity levels in vivo utilizing apobec-1(-/-) mice. Insulin did not significantly alter hepatic MTP mRNA levels or lipid transfer activity 2h following injection, but suppressed expression of genes important in gluconeogenesis. To study the specific role of MTP, we expressed human MTP (hMTP) in primary rat hepatocytes using adenoviral gene transfer. Increased expression of hMTP resulted in a 47.6±17.9% increase in total apo B secreted. Incubation of hepatocytes with insulin suppressed apo B secretion by 50.1±10.8% in cells over-expressing hMTP and by 53.0±12.4% in control transfected hepatocytes. Results indicate that even under conditions of increased hepatic apo B secretion mediated by MTP, responsiveness of hepatocytes to insulin to suppress apo B secretion is maintained.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316344      PMCID: PMC3056943          DOI: 10.1016/j.bbrc.2011.02.028

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  FoxO1 and hepatic lipid metabolism.

Authors:  Janet D Sparks; Henry H Dong
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

2.  MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion.

Authors:  M Shiomi; T Ito
Journal:  Eur J Pharmacol       Date:  2001-11-09       Impact factor: 4.432

3.  The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life.

Authors:  C R Pullinger; J D North; B B Teng; V A Rifici; A E Ronhild de Brito; J Scott
Journal:  J Lipid Res       Date:  1989-07       Impact factor: 5.922

4.  Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein.

Authors:  Paul Rava; Humra Athar; Caroline Johnson; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2005-05-16       Impact factor: 5.922

5.  Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38.

Authors:  Wo-Shing Au; Hsiang-fu Kung; Marie C Lin
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

Review 6.  New approaches to target microsomal triglyceride transfer protein.

Authors:  Mohammed Mahmood Hussain; Ahmed Bakillah
Journal:  Curr Opin Lipidol       Date:  2008-12       Impact factor: 4.776

7.  CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.

Authors:  Charles E Chandler; Donald E Wilder; Judith L Pettini; Yvette E Savoy; Stephen F Petras; George Chang; John Vincent; H James Harwood
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

8.  Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells.

Authors:  G Ogbonna; A Theriault; K Adeli
Journal:  Int J Biochem       Date:  1993-05

9.  Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression.

Authors:  M C Lin; D Gordon; J R Wetterau
Journal:  J Lipid Res       Date:  1995-05       Impact factor: 5.922

10.  Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin.

Authors:  N A Elshourbagy; M S Boguski; W S Liao; L S Jefferson; J I Gordon; J M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more
  8 in total

Review 1.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

Review 2.  Dyslipidaemia of diabetes and the intestine.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  World J Diabetes       Date:  2015-07-10

3.  Regulation of microsomal triglyceride transfer protein.

Authors:  M Mahmood Hussain; Niels Nijstad; Lisa Franceschini
Journal:  Clin Lipidol       Date:  2011-06

4.  Insulin dependent apolipoprotein B degradation and phosphatidylinositide 3-kinase activation with microsomal translocation are restored in McArdle RH7777 cells following serum deprivation.

Authors:  Janet D Sparks; Amy L Magra; Jeffrey M Chamberlain; Colleen O'Dell; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2015-11-23       Impact factor: 3.575

5.  Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.

Authors:  Janet D Sparks; Colleen O'Dell; Jeffrey M Chamberlain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2013-05-15       Impact factor: 3.575

6.  An Allosteric Binding Site on Sortilin Regulates the Trafficking of VLDL, PCSK9, and LDLR in Hepatocytes.

Authors:  Robert P Sparks; Andres S Arango; Jermaine L Jenkins; Wayne C Guida; Emad Tajkhorshid; Charles E Sparks; Janet D Sparks; Rutilio A Fratti
Journal:  Biochemistry       Date:  2020-11-05       Impact factor: 3.162

Review 7.  The regulation of ApoB metabolism by insulin.

Authors:  Mary E Haas; Alan D Attie; Sudha B Biddinger
Journal:  Trends Endocrinol Metab       Date:  2013-05-27       Impact factor: 12.015

8.  Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.

Authors:  Eric Fisher; Elizabeth Lake; Roger S McLeod
Journal:  J Biomed Res       Date:  2014-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.